Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.
Nucl Med Biol. 2018 Jul-Aug;62-63:71-77. doi: 10.1016/j.nucmedbio.2018.06.001. Epub 2018 Jun 8.
Nucl Med Biol. 2018.
PMID: 29929115
Free PMC article.
Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
Stott Reynolds TJ, Schehr R, Liu D, Xu J, Miao Y, Hoffman TJ, Rold TL, Lewis MR, Smith CJ.
Stott Reynolds TJ, et al.
Nucl Med Biol. 2015 Feb;42(2):99-108. doi: 10.1016/j.nucmedbio.2014.10.002. Epub 2014 Oct 13.
Nucl Med Biol. 2015.
PMID: 25459113
Item in Clipboard
Peptide-Based Radiopharmaceuticals for Molecular Imaging of Prostate Cancer.
Stott Reynolds TJ, Smith CJ, Lewis MR.
Stott Reynolds TJ, et al.
Adv Exp Med Biol. 2018;1096:135-158. doi: 10.1007/978-3-319-99286-0_8.
Adv Exp Med Biol. 2018.
PMID: 30324352
Review.
Item in Clipboard
Cite
Cite